» Articles » PMID: 32889231

T-cell Repertoire Analysis and Metrics of Diversity and Clonality

Overview
Publisher Elsevier
Specialty Biotechnology
Date 2020 Sep 5
PMID 32889231
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

The recent developments of high-throughput bulk and single-cell sequencing technologies accelerated the understanding of the complexity of immune repertoire dynamics combined to transcriptomics. Also, profiling of cellular repertoires in health or disease requires statistical metrics to capture clonal diversity characterized by clones frequency, repertoire richness and convergence. Here we present the common technologies of bulk and single-cell sequencing of T-cell receptors (TCRs), discuss current knowledge regarding computational tools clustering and predicting specificity of TCR repertoires based on shared structural motifs and review main indices for repertoire diversity and convergence analyses. These tools represent potential biomarkers to decipher the fitness of immune repertoires in diseased or treated patients but also the presages and promises of computational approaches to revolutionize personalized immunotherapy.

Citing Articles

Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis.

Sun H, Zhu X, Wang Z, Gao Q, Ji Y, Shi Y BMJ Oncol. 2025; 3(1):e000578.

PMID: 40046248 PMC: 11880783. DOI: 10.1136/bmjonc-2024-000578.


Integrating single-cell RNA and T cell/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age.

Wang Y, Li R, Tong R, Chen T, Sun M, Luo L Nat Immunol. 2025; 26(2):308-322.

PMID: 39881000 PMC: 11785523. DOI: 10.1038/s41590-024-02059-6.


Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myeloma.

Dhakal B, Hari P, Chhabra S, Szabo A, Lum L, Glass D J Immunother Cancer. 2025; 13(1).

PMID: 39875173 PMC: 11781102. DOI: 10.1136/jitc-2024-010649.


Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia.

Barakos G, Georgoulis V, Koumpis E, Hatzimichael E Diseases. 2025; 13(1).

PMID: 39851483 PMC: 11765071. DOI: 10.3390/diseases13010019.


T-cell Receptor Repertoire Analysis in the Context of Transarterial Chemoembolization Synergy with Systemic Therapy for Hepatocellular Carcinoma.

Li J, Zhang Y, Hu L, Ye H, Yan X, Li X J Clin Transl Hepatol. 2025; 13(1):69-83.

PMID: 39801788 PMC: 11712086. DOI: 10.14218/JCTH.2024.00238.